drugset / Trial / NCT05643508

A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

NCT05643508 ↗

Phase 3 Completed 214 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the efficacy and safety of co-administration of DWC202206 and DWC202207 in patients with concomitant hypertension and hyperlipidemia.

Timeline

Start
2023-02-23
Primary completion
2024-09-10
Completion
2024-09-10

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC202206 Unknown — —
Subject DWC202207 Unknown — —